Corbus Pharmaceuticals Holdings Inc (CRBP)
17.87
-0.11
(-0.61%)
USD |
NASDAQ |
Nov 27, 15:35
Corbus Pharmaceuticals Holdings Shareholders Equity (Quarterly): 150.50M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 150.50M |
| June 30, 2024 | 125.54M |
| March 31, 2024 | 96.97M |
| December 31, 2023 | -6.905M |
| September 30, 2023 | 0.311M |
| June 30, 2023 | 9.521M |
| March 31, 2023 | 16.46M |
| December 31, 2022 | 32.99M |
| September 30, 2022 | 41.95M |
| June 30, 2022 | 49.47M |
| March 31, 2022 | 61.16M |
| December 31, 2021 | 69.11M |
| September 30, 2021 | 77.63M |
| June 30, 2021 | 76.96M |
| March 31, 2021 | 91.52M |
| December 31, 2020 | 45.27M |
| September 30, 2020 | 29.23M |
| June 30, 2020 | 48.41M |
| March 31, 2020 | 22.69M |
| December 31, 2019 | 6.158M |
| September 30, 2019 | 29.64M |
| Date | Value |
|---|---|
| June 30, 2019 | 47.37M |
| March 31, 2019 | 42.30M |
| December 31, 2018 | 27.52M |
| September 30, 2018 | 42.87M |
| June 30, 2018 | 55.49M |
| March 31, 2018 | 65.54M |
| December 31, 2017 | 57.78M |
| September 30, 2017 | 31.98M |
| June 30, 2017 | 37.59M |
| March 31, 2017 | 43.59M |
| December 31, 2016 | 8.919M |
| September 30, 2016 | 13.31M |
| June 30, 2016 | 17.65M |
| March 31, 2016 | 6.404M |
| December 31, 2015 | 8.985M |
| September 30, 2015 | 11.17M |
| June 30, 2015 | 6.769M |
| March 31, 2015 | 4.692M |
| December 31, 2014 | 5.863M |
| September 30, 2014 | 7.016M |
| December 31, 2013 | -1.783M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-6.905M
Minimum
Dec 2023
150.50M
Maximum
Sep 2024
52.25M
Average
46.84M
Median
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 2.912M |
| Perspective Therapeutics Inc | 328.47M |
| Protalix BioTherapeutics Inc | 32.44M |
| Electromed Inc | 41.49M |
| Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 164.17M |
| Total Liabilities (Quarterly) | 13.67M |